What is Cytokinetics's debt conversion expense?

Cytokinetics (CYTK) reported debt conversion expense of $121.25M in Q3 2025.

What does debt conversion expense mean?

The accounting cost incurred when debt is converted into company stock.

How do you interpret debt conversion expense?

An increase indicates significant debt-to-equity conversion activity, which may reduce future interest obligations but dilutes existing shareholders.

How does debt conversion expense compare across companies?

Common in growth-stage biotech companies utilizing convertible debt to fund clinical trials.

Cytokinetics CYTK Debt Conversion Expense

Discontinued — last reported Q3 '25

Debt Conversion Expense at other companies

Antero ResourcesAR

$288K—

Antero ResourcesAR

$288K—

Booking Holdings Inc.BKNG

$0+100%

SemtechSMTC

$1.15M—

SemtechSMTC

——

SynopsysSNPS

——

Other financials

Income statement

See full

Revenue$19.4M+1,126%

Operating income-$183.6M-18.0%

Net income-$206.0M-27.7%

EPS (diluted)-$1.67-22.8%

Balance sheet

See full

Cash & equivalents$129.8M+76.2%

Total debt$418.2M+75.8%

Total equity-$826.6M-210%

Total assets$1.3B+0.7%

Cash flow

See full

Operating cash flow-$145.5M-10.5%

CapEx$5.9M+4.7%

Free cash flow-$151.4M-10.3%

Valuation

See full

Market cap$10.7B+70.6%

Enterprise value$10.98B+70.7%

P/S101.1×-225×

Profitability

See full

Operating margin-605.1%-268pp

Net margin-784%-337pp

FCF margin-518.8%-223pp

Returns & leverage

See full

Return on equity-337.6%—

Debt / equity2.2×—

Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept cytk:DebtConversionExpense.

The official record: Cytokinetics’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's debt conversion expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytokinetics's debt conversion expense?: Cytokinetics (CYTK) reported debt conversion expense of $121.25M in Q3 2025.
What does debt conversion expense mean?: The accounting cost incurred when debt is converted into company stock.
How do you interpret debt conversion expense?: An increase indicates significant debt-to-equity conversion activity, which may reduce future interest obligations but dilutes existing shareholders.
How does debt conversion expense compare across companies?: Common in growth-stage biotech companies utilizing convertible debt to fund clinical trials.